London Institute of Cancer Research Welcomes MHRA Approval of Breast Cancer Drug That Targets Tumours Before They Have a Chance to Grow
August 08, 2026
August 08, 2026
LONDON, England, Aug. 8 (TNSjou) -- The Institute of Cancer Research issued the following news:
* * *
ICR welcomes MHRA approval of breast cancer drug that targets tumours before they have a chance to grow
The Institute of Cancer Research, London, strongly welcomes the news that camizestrant, a powerful new drug for advanced breast cancer that can be used to treat emerging tumours, has been approved by the medicines regulator, the MHRA.
The dru . . .
* * *
ICR welcomes MHRA approval of breast cancer drug that targets tumours before they have a chance to grow
The Institute of Cancer Research, London, strongly welcomes the news that camizestrant, a powerful new drug for advanced breast cancer that can be used to treat emerging tumours, has been approved by the medicines regulator, the MHRA.
The dru . . .